キャノピ―・グロ―ス

 CGCのチャート


 CGCの企業情報

symbol CGC
会社名 Canopy Growth Corp (キャノピ―・グロ―ス)
分野(sector)   
産業(industry)   
業種    医療関連(Health Care)
概要 ―  キャノピ―・グロ―スはカナダの医療用大麻製造会社。乾燥、オイル、ソフトジェルタイプなど、主に医療用大麻の製造を手掛ける。また、産業用ヘンプの栽培を行い、食品、化粧品、繊維、工業用製品や、医療用のCBD(カンナビジオ―ル)などの原料を供給する。製品は国内向けのほか、大麻が合法化されている国へ販売する。本社所在地はオンタリオ州スミスフォ―ルズ。  
本社所在地 1 Hershey Drive Smiths Falls Ontario K7A 0A8 CAN
代表者氏名
代表者役職名
電話番号
設立年月日 40026
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 1033人
url www.canopygrowth.com
nasdaq_url
adr_tso
EBITDA
終値(lastsale)
時価総額(marketcap)
時価総額
売上高
企業価値(EV)
当期純利益
決算概要

 CGCのテクニカル分析


 CGCのニュース

   Houseplant, Seth Rogen And Evan Goldberg's Cannabis Brand, To Debut In The US  2021/03/01 22:02:29 Benzinga
Houseplant , Seth Rogen and Evan Goldberg’s cannabis and lifestyle brand, is launching in the U.S. on March 11. The brand was founded in Canada back in April 2019 in partnership with cannabis giant Canopy Growth Corp. (NYSE: CGC ). Since then, it has become one of the most coveted celebrity-backed brands in the cannabis industry. In an email to Benzinga, Houseplant explained that, even though Canopy will continue to be its licensee in Canada, it is not involved in the U.S. launch. “We are thrilled to launch in the US, bringing cannabis products to our fellow Californians and an original line of Housegoods to consumers nationwide," Houseplant co-founder and CEO Michael Mohr told Benzinga. "It is only … Full story available on Benzinga.com
   Cannabidiol (CBD) Market to See Booming Growth | Elixinol, Aphria, Canopy Growth, NuLeaf Naturals  2021/02/27 09:00:07 OpenPR
Stay up-to-date and exploit latest trends of Cannabidiol (CBD) Market with latest edition released by AMA. Cannabidiol (CBD) Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Cannabidiol (CBD) industry with an
   Canopy Growth's Chief Product Officer On How COVID-19 Accelerated Cannabis Demand  2021/02/26 21:32:50 Benzinga
The COVID-19 pandemic accelerated demand for tools to cope with stress management and anxiety, Canopy Growth Corp (NASDAQ: CGC ) President and Chief Product Officer Rade Kovacevic said Friday during Benzinga's Cannabis Capital Conference . Cannabis And Stress Management: It goes without saying that rising anxiety is a trend that was seen worldwide, and this created new opportunities for both the cannabis industry as a whole and Canopy Growth , Kovacevic said during the virtual Benzinga conference. He called Canopy's Storz & Bickel the "gold standard" for luxury cannabis goods and said the brand benefited from consumers demanding the best product to help cope with never-ending Zoom meetings and life at home. The CBD space is perhaps best known for its stress management characteristics, so sales were naturally higher throughout 2020, … Full story available on Benzinga.com
   Item 9 Labs and Why Franchising is the Growth Vehicle to Propel the Cannabis Industry  2021/02/26 15:06:38 Benzinga
Item 9 Labs Corp. is a sponsor and will speak at the Benzinga Cannabis Capital Conference set to take place on February 25-26, 2021. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. The cannabis industry is having a prime moment and a promising horizon ahead. After a transformative 2020, the market is experiencing policy changes worldwide, rising cannabis stocks and a high demand that positions the industry for exponential growth in the coming years. Additionally, Mergers and Acquisitions ( M&A) activity is expected to increase as cannabis stock valuations are becoming more realistic. In fact, many M&As are taking place all over the industry, reinforcing this trend. For example, Jazz Pharmaceuticals (NASDAQ: JAZZ ) has inked a deal to acquire GW Pharmaceuticals (NASDAQ: GWPH ), Cresco Labs (OTC: CRLBF ) acquired Origin House , and Canopy Growth Corp. (NASDAQ: CGC ) and Acreage Holdings (OTC: ACRHF ) are en route to merge.
   The world's largest cannabis companies are jockeying to dominate the lucrative US market. 7 top CEOs and executives break down the deals you can expect.  2021/02/25 14:23:10 Business Insider
Summary List Placement The US cannabis industry is set for a flurry of deals as Democrats on Capitol Hill make cannabis reform a core issue and new state markets open. Insider spoke with top executives at seven of the largest cannabis companies. They said that they'll be focused on expanding their footprints as new state markets open up. They also said they'd use deals to scoop up valuable intellectual property as they jockey for control of the lucrative US market. And there is another battle looming: Canadian companies like Canopy Growth, Aurora, Tilray, and Aphria, are all preparing to enter the US market as soon as they can, encroaching on US firms like Green Thumb Industries and Curaleaf. "These businesses, ours included, are going to become very big and very well-capitalized." Ben Kovler, the CEO of US cannabis company Green Thumb Industries (GTI) told Insider. In the US, cannabis is legal in 15 states for recreational purposes and in 36 states for medical use. Cowen analyst Vivien Azer has projected that the legal US cannabis industry could balloon to a $100 billion market by 2030, and companies are working hard to ensure that they'll win a slice of that.
   The Week In Cannabis: Epidiolex, Casa Verde, FDA, Michigan, Colombia, And More  2020/12/24 19:05:34 Benzinga
After a weak start to a shortened week, cannabis stocks rebounded on Wednesday afternoon, advancing on high volume, with some giving up the gains on Thursday morning. Over the 3 1/2 trading days of the week: The ETFMG Alternative Harvest ETF (NYSE: MJ ): gained 1% The AdvisorShares Pure Cannabis ETF (NYSE: YOLO ): was up 5.2% The Cannabis ETF (NYSE: THCX ): was almost flat. The Amplify Seymour Cannabis ETF (NYSE: CNBS ): advanced 5.5% The SPDR S&P 500 ETF Trust (NYSE: SPY ) was up 1%. In addition, GW Pharmaceuticals plc (NASDAQ: GWPH ) published positive results for its Phase 3 clinical trial of Epidiolex oral solution in seizures related to tuberous sclerosis complex in JAMA Neurology. Epidiolex is the first FDA-authorized CBD medicine for children with severe forms of epilepsy. The medicine was first approved for treatments of seizures connected to Lennox-Gastaut syndrome and Dravet syndrome. Michigan Gov. Gretchen Whitmer commuted the sentence of Last Prisoner Project’s constituent Michael Thompson, who spent 25 years in prison after a 1994 arrest of a nonviolent cannabis sale. “I’m thankful to everybody that was involved and I’m thankful to Gov.
   David Olive: The Faceoff: The newly-merged Tilray is now the world’s largest pot company — but its merger might actually give rival Canopy a heated edge  2020/12/19 17:00:00 The Star
This week’s merger of pot giants Aphria and Tilray has displaced Canopy Growth by a wide margin as the world’s largest cannabis company — but king-of-the-pot-hill status may still prove fleeting, David Olive writes.
   Global Cannabis Market Report 2020 Featuring Aphria, Aurora Cannabis, Cannabis Science, Canopy Growth, Medical Marijuana, Inc, VIVO Cannabis, Tikun Olam, Terra Tech, Tilray and The Cronos Group  2020/12/18 15:30:00 PR Newswire
DUBLIN, Dec. 18, 2020 /PRNewswire/ -- The "Cannabis Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type; Application; and Geography" report has been added to ResearchAndMarkets.com's offering. Tetrahydrocannabinol-Dominant Segment to Register Highest CAGR in…
   See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad  2020/12/18 09:00:00 Business Insider
Summary List Placement Cosmo Feilding Mellen was involved in the world of psychedelics long before the compounds started to become mainstream. Feilding Mellen is the cofounder and CEO of UK-based psychedelics company Beckley Psytech, but his family — and his mother Amanda Feilding, in particular — has been involved in the scientific studies around psychedelics since 1998. That's the year Feilding started the Beckley Foundation, a non-profit focused on drug policy reform and scientific research into psychoactive substances. Feilding, dubbed the Countess of Cannabis , has been a long-time advocate for psychedelics-based therapies and is a leading advocate for reform for medical cannabis in Europe. She is currently chair of Beckley Psytech's Scientific Advisory Board. Before starting Beckley Psytech, Feilding Mellen was deeply involved in the Beckley Foundation, which has partnered in joint research collaborations with institutions like Imperial College London and Johns Hopkins in clinical trials of psychedelic compounds over the past 20 years.
   $1,000 Invested in Canopy Growth (TSX:WEED) Stock Would Be Worth This Much Today  2020/12/17 15:12:11 The Motley Fool Canada
Will Canopy Growth (TSX:WEED) stock move higher after a 24% gain in 2020? The post $1,000 Invested in Canopy Growth (TSX:WEED) Stock Would Be Worth This Much Today appeared first on The Motley Fool Canada .
   Kursziele aktualisiert: Wie laut Analysten die Chancen von Aurora Cannabis und Canopy Growth stehen  2020/11/27 02:26:20 Finanzen CH
• Canopy und Aurora legen Zahlen vor • Wendepunkt am Markt erreicht? • Kursziele mehrheitlich angehoben Cannabis-Marktführer legen Zahlen vor Der kanadische Cannabis-Sektor war in letzter Zeit volatil. Angeführt wurde diese Unsicherheit von der Bekanntgabe von Quartalszahlen von Cannabisherstellern.
   Cannabis Stocks Surge as Election Opens New Markets  2020/11/25 14:00:24 Newsmax Media
Cannabis Stocks Surge as US Election Opens New Markets; Shares in some of the biggest cannabis companies, including Aurora Cannabis, Canopy Growth and Cresco Labs, are up between 24% and 75% so far this month. By comparison, the benchmark S&P 500 index is up 11%.
   Stock Market: Legal Marijuana Market Size, Statistical Analysis 2020 By Top Key Vendors Aurora Cannabis, Canopy Growth, Terra Tech Corp, Stenocare, Tikun Olam  2020/11/25 13:47:15 OpenPR
Legal Marijuana Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of legal Marijuana market with detailed market
   Canopy Growth Is Turning Around, Leaving CGC Stock a Huge Upside  2020/11/25 12:34:27 InvestorPlace
Canopy Growth is turning around, leaving CGC stock a huge upside. It's likely to benefit from the company's clearer path to profitability.
   Canopy Growth (TSX:WEED) Addressed a Key Concern for Cannabis Investors  2020/11/24 16:30:31 The Motley Fool Canada
Canopy Growth (TSX:WEED)(NYSE:CGC) has just added critical data to the cannabis body of knowledge. Investors in cannabis stocks should appreciate it. The post Canopy Growth (TSX:WEED) Addressed a Key Concern for Cannabis Investors appeared first on The Motley Fool Canada .

 関連キーワード  (― 米国株 キャノピ―・グロ―ス CGC )

 twitter  (公式ツイッターやCEOツイッターなど)